• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Dazoxiben Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758821

MBS5758821 is an inhibitor targeting Dazoxiben. Dazoxiben is a potent inhibitor of thromboxane (TX) synthase More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Dazoxiben, Inhibitor
Full Product Name
Dazoxiben
Product Synonym Names
UK-37248
Form/Format
Solid. Powder
Purity/Purification
99.94%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
268.70
Solubility
DMSO: 62.5mg/mL (232.60mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C12H13ClN2O3
SMILES
Cl.O=C(O)c1ccc(OCCn2ccnc2)cc1
CAS Number
74226-22-5
Target & IC50
Thromboxane (TX) synthase
In Vitro
Dazoxiben, an orally active TX-synthase inhibitor, on platelet and renal TXB2 production and associated changes in PG-endoperoxide metabolism. Dazoxiben inhibits TXB2 production in clotting human whole blood with an IC50 of 0.3 micrograms/ml and causes parallel enhancement of PGE2 greater than PGF2 alpha greater than 6-keto-PGF1 alpha production[1].

Structure of Dazoxiben, inhibitor

Dazoxiben Inhibitor – Cat# MBS5758821

Product References and Citations for Dazoxiben, inhibitor

Patrignani P, Filabozzi P, Catella F, et al. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.[J]. journal of pharmacology & experimental therapeutics, 1984, 228(2):472-477.
Patrignani P, Filabozzi P, Catella F, et al. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.[J]. journal of pharmacology & experimental therapeutics, 1984, 228(2):472-477.
Yu S M, Wu T S, Teng C M. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor[J]. British Journal of Pharmacology, 1994, 111(3).
Yu S M, Wu T S, Teng C M. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor[J]. British Journal of Pharmacology, 1994, 111(3).

Other Notes

Small volumes of Dazoxiben, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000